Pillar 2 · Sleep and PTSD
睡眠とPTSD — 病態メカニズムと治療技術開発
Does a disrupted sleep cycle keep trauma memories from fading? We carry the answer into SES, an investigational platform.
We pair animal studies of trauma-related fear memory with clinical studies in patients with PTSD, and translate the findings into a sleep-based therapeutic technology — Sound Exposure during Sleep (SES).
Pursuing PTSD research at Kobe University carries a particular sense of mission. In 1995 this city was struck by the Great Hanshin–Awaji Earthquake, and many in this region have lived with its lasting psychological aftermath. As a laboratory rooted in this place, we take seriously the responsibility of understanding trauma-related conditions and developing therapeutic technologies. This page provides scientific context only — it is not a channel for medical advice, and it is not a recruitment channel for any clinical study.
Pillar 2 · 2a
Animal: pathophysiology of trauma-related fear memory
Pillar 2 · 2b
Clinical: sleep-rhythm signatures of PTSD
In a recent preprint we report what we believe to be the first description of altered NREM–REM cycle transitions in people with PTSD (Sekiba et al., medRxiv 2025; preprint, peer review pending). This signature provides both a candidate biomarker and a hypothesis for how disturbed sleep cycles may underlie persistent fear memory in PTSD.
Pillar 2 · 2c
Clinical: Sound Exposure during Sleep (SES) — therapeutic technology development
Sound Exposure during Sleep (SES) is our laboratory's investigational platform. It delivers individualized auditory cues during specific sleep stages, leveraging endogenous sleep-dependent memory processing to help modulate trauma-related memory processing.
We have successfully completed a medical-institution-led, First-in-Human feasibility study of SES (registered as jRCT1030230706). 13 patients provided informed consent and 6 completed overnight SES. The intervention proved well tolerated: slow-wave sleep was preserved and no adverse events were attributed to the auditory cues, supporting feasibility and safety. Exploratory analyses are described in the preprint (Ino et al., medRxiv 2026).
SES remains an investigational platform; this site provides no medical advice, and the registered study has concluded.
Key publications: see Publications →